参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/06/02 | 1,267 | 1,277 | 1,264 | 1,277 | +3 | +0.2% | 1,126,900 |
2023/06/01 | 1,270 | 1,279 | 1,258 | 1,274 | +7 | +0.6% | 1,117,600 |
2023/05/31 | 1,274 | 1,282 | 1,259 | 1,267 | -27 | -2.1% | 3,430,000 |
2023/05/30 | 1,307 | 1,317 | 1,286 | 1,294 | +3 | +0.2% | 1,577,900 |
2023/05/29 | 1,290 | 1,298 | 1,280 | 1,291 | +12 | +0.9% | 1,135,600 |
2023/05/26 | 1,274 | 1,294 | 1,269 | 1,279 | -3 | -0.2% | 1,290,100 |
2023/05/25 | 1,286 | 1,300 | 1,275 | 1,282 | +6 | +0.5% | 2,044,200 |
2023/05/24 | 1,322 | 1,322 | 1,273 | 1,276 | -46 | -3.5% | 2,337,500 |
2023/05/23 | 1,335 | 1,338 | 1,312 | 1,322 | +17 | +1.3% | 2,358,800 |
2023/05/22 | 1,300 | 1,310 | 1,291 | 1,305 | +24 | +1.9% | 1,921,200 |
2023/05/19 | 1,254 | 1,287 | 1,250 | 1,281 | +31 | +2.5% | 2,704,100 |
2023/05/18 | 1,255 | 1,256 | 1,244 | 1,250 | -4 | -0.3% | 1,077,300 |
2023/05/17 | 1,250 | 1,254 | 1,239 | 1,254 | +2 | +0.2% | 1,210,300 |
2023/05/16 | 1,234 | 1,252 | 1,231 | 1,252 | +19 | +1.5% | 1,981,300 |
2023/05/15 | 1,219 | 1,237 | 1,205 | 1,233 | +12 | +1% | 2,262,400 |
2023/05/12 | 1,188 | 1,231 | 1,171 | 1,221 | +63 | +5.4% | 4,332,900 |
2023/05/11 | 1,161 | 1,163 | 1,147 | 1,158 | +6 | +0.5% | 1,329,300 |
2023/05/10 | 1,154 | 1,161 | 1,144 | 1,152 | -4 | -0.3% | 1,319,200 |
2023/05/09 | 1,148 | 1,163 | 1,148 | 1,156 | +4 | +0.3% | 987,500 |
2023/05/08 | 1,157 | 1,161 | 1,147 | 1,152 | +1 | +0.1% | 1,050,800 |
2023/05/02 | 1,170 | 1,171 | 1,141 | 1,151 | -12 | -1% | 1,007,300 |
2023/05/01 | 1,157 | 1,163 | 1,148 | 1,163 | +22 | +1.9% | 1,634,400 |
2023/04/28 | 1,124 | 1,157 | 1,119 | 1,141 | +47 | +4.3% | 2,732,000 |
2023/04/27 | 1,080 | 1,095 | 1,075 | 1,094 | ±0 | ±0% | 1,981,900 |
2023/04/26 | 1,092 | 1,099 | 1,086 | 1,094 | +4 | +0.4% | 1,830,300 |
2023/04/25 | 1,087 | 1,098 | 1,086 | 1,090 | +3 | +0.3% | 1,014,000 |
2023/04/24 | 1,092 | 1,098 | 1,086 | 1,087 | +2 | +0.2% | 1,086,300 |
2023/04/21 | 1,077 | 1,093 | 1,072 | 1,085 | +14 | +1.3% | 1,522,800 |
2023/04/20 | 1,078 | 1,078 | 1,061 | 1,071 | +1 | +0.1% | 1,967,600 |
2023/04/19 | 1,081 | 1,081 | 1,060 | 1,070 | -14 | -1.3% | 2,016,300 |
2023/04/18 | 1,094 | 1,095 | 1,075 | 1,084 | -11 | -1% | 1,952,300 |
2023/04/17 | 1,111 | 1,114 | 1,086 | 1,095 | -16 | -1.4% | 1,433,200 |
2023/04/14 | 1,103 | 1,123 | 1,101 | 1,111 | -4 | -0.4% | 1,587,600 |
2023/04/13 | 1,116 | 1,118 | 1,103 | 1,115 | +11 | +1% | 1,357,200 |
2023/04/12 | 1,112 | 1,117 | 1,099 | 1,104 | -8 | -0.7% | 1,221,700 |
2023/04/11 | 1,119 | 1,123 | 1,106 | 1,112 | +1 | +0.1% | 1,244,600 |
2023/04/10 | 1,110 | 1,120 | 1,106 | 1,111 | +2 | +0.2% | 804,300 |
2023/04/07 | 1,118 | 1,120 | 1,107 | 1,109 | -4 | -0.4% | 1,033,600 |
2023/04/06 | 1,105 | 1,115 | 1,099 | 1,113 | -1 | -0.1% | 1,362,300 |
2023/04/05 | 1,138 | 1,139 | 1,112 | 1,114 | -25 | -2.2% | 1,348,900 |
2023/04/04 | 1,130 | 1,151 | 1,125 | 1,139 | +13 | +1.2% | 1,654,400 |
2023/04/03 | 1,138 | 1,142 | 1,120 | 1,126 | -4 | -0.4% | 999,000 |
2023/03/31 | 1,113 | 1,133 | 1,112 | 1,130 | +11 | +1% | 1,705,300 |
2023/03/30 | 1,130 | 1,130 | 1,114 | 1,119 | -20 | -1.8% | 1,319,700 |
2023/03/29 | 1,132 | 1,141 | 1,121 | 1,139 | +7 | +0.6% | 1,749,300 |
2023/03/28 | 1,145 | 1,148 | 1,121 | 1,132 | -10 | -0.9% | 1,977,200 |
2023/03/27 | 1,127 | 1,147 | 1,118 | 1,142 | +30 | +2.7% | 2,225,000 |
2023/03/24 | 1,095 | 1,117 | 1,082 | 1,112 | +22 | +2% | 2,047,200 |
2023/03/23 | 1,093 | 1,101 | 1,089 | 1,090 | -11 | -1% | 1,592,800 |
2023/03/22 | 1,105 | 1,115 | 1,097 | 1,101 | +18 | +1.7% | 2,342,600 |
451~
500
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 143,100円 | 0.0% | +50.6% | 2.52% | 15.03倍 | 1.69倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 162,800円 | -3.5% | -50.2% | 4.91% | 13.19倍 | 0.98倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 218,000円 | +18.2% | +4.2% | 1.65% | 15.30倍 | 1.95倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
久光薬 | 402,500円 | +8.7% | +17.1% | 2.24% | 14.32倍 | 1.07倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 420,100円 | +20.9% | +87.3% | 3.24% | 9.38倍 | 1.08倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム